Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 11.9811.182.948.04-2.50

What is the latest Core EBITDA Margin ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of AKUMS DRUGS & PHARMACEUTICALS is 11.98 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202611.98
Mar202511.18
Mar20242.94
Mar20238.04
Mar2022-2.50

How is Core EBITDA Margin of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2026 11.98
7.16
Mar2025 11.18
280.27
Mar2024 2.94
-63.43
Mar2023 8.04
Positive
Mar2022 -2.5 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹12,804.5 Cr -0.7% 4.4% 78.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

-0.7%

4.4%

78.8%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses